Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.63 |
| ▸ | MGAM | O43451 | 10/20 | 0.63 |
| ▸ | AMY1A | P0DUB6 | 10/20 | 0.63 |
| ▸ | SI | P14410 | 10/20 | 0.63 |
| ▸ | MGAM2 | Q2M2H8 | 10/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | LIPE | Q05469 | 2/20 | 0.41 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11357912 | 0.83 | MGAM (0.59) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL425552 | 0.83 | KMT2A (0.59) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL427449 | 0.82 | GLA (0.47) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL427465 | 0.82 | KCNMA1 (0.55) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL7906221 | 0.82 | SMN1; SMN2 (0.47) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL445611 | 0.82 | GAA (0.45) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL7899312 | 0.77 | KMT2A (0.59) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL427308 | 0.76 | KMT2A (0.70) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL10428645 | 0.76 | GAA (0.67) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL425440 | 0.73 | F12 (0.60) | GAAMGAMAMY1ASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353082-B2 | Pharmaceutical compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-05-31 | — | — | US | disclosed |
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | FAAH, FAAH2, ASAH1 | GAA 184/4885MGAM 1034/4885AMY1A 955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.